Delivery Order SPE2DB20D9214-SPE2DB25FD4XU
Award Date 9/15/25
Potential Completion Date 10/6/25
Potential Value $32K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for Stelara 90 mg/mL syringes valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 15, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 8, 2025, represents a standard procurement action with no set-aside designation. The contract will be performed at the awardee's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for STELARA 90 mg/mL syringes. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Stelara 90 mg/mL syringes. The award represents a firm fixed-price delivery order with no set-aside designation, utilizing the company's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The product will be delivered to Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 16, 2025, by the Defense Logistics Agency (DLA) for Stelara 90 mg/mL syringes, valued at $16,249.95. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $500 million and extends through November 2026. The delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Stelara 130 mg/26 ml vials. The contract, valued at $5,049.84 with a firm fixed price structure, represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on September 11, 2025. The contract calls for the delivery of Stelara 90 mg/ml syringes, a biologic immunosuppressant medication used to treat autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The contract, awarded on September 15, 2025, carries a firm fixed-price structure with an ultimate completion date of October 6, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $16,249.95 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Stelara 90 mg/ml syringes. The contract carries an ultimate completion date of October 2, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $35,924.34 on July 18, 2025, for the supply of Stelara 90mg/ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation. The funding source is the Medical Supply Chain, a defense-oriented federal agency, and the place of performance is Park Ridge,...